MMP9 and amyotrophic lateral sclerosis: OPN is involved in the second wave of neurodegeneration in ALS, during which MMP-9 makes ALS-resistant FR/S MNs vulnerable to SOD1-mediated toxicity around the time of clinical disease onset.